Target intelligence / Profile preview

Tensin-1 (TNS1)

Target
TNS1
Molecular classification
Cytoskeleton-associated protein, Scaffold/adaptor protein, Focal adhesion protein, PTP-C2 superfamily (contains protein tyrosine phosphatase-like and C2 domains, although the PTP domain is catalytically inactive in TNS1), Other
01

Overview

Tensin-1 is a large multidomain scaffolding protein that localizes to focal adhesions, specialized plasma membrane structures where it links the actin cytoskeleton to integrin receptors and supports cell-matrix adhesion[2][3][4][1]. It contains a phosphotyrosine-binding domain that interacts with the cytoplasmic tails of β integrins, and a protein tyrosine phosphatase (PTP) domain that is catalytically inactive in Tensin-1, distinguishing it from enzymatically active PTP family members[2][4]. Tensin-1 participates in organizing actin filaments, modulating signaling pathways, and regulating cellular processes such as migration, polarity, and ECM assembly[1][3][4]. Phase separation properties have recently been described, with Tensin-1 forming membraneless biomolecular condensates during focal adhesion disassembly, highlighting a role in cell cycle-dependent adhesion and signaling dynamics[1]. Dysregulation of Tensin-1 expression or post-translational modification is implicated in lung diseases, tissue remodeling, and cancers, but it is not currently a direct therapeutic target.

Other names
Tensin-1TNS1TNSProtein phosphatase 1 regulatory subunit 155PPP1R155Matrix-remodelling-associated protein 6MXRA6MST091MST122MST127MSTP091MSTP122MSTP127DKFZp586K0617matrix-remodelling associated 6
02

Biological functions

Cell adhesionLinkage of actin cytoskeleton to integrinsSignal transduction (outside-in and inside-out via integrin complexes)Regulation of cell migration, polarization, and spreadingFibrillar adhesion and extracellular matrix (ECM) assemblyMechanotransduction (sensing and transmitting mechanical cues)
03

Disease associations

Cancer (notably lung adenocarcinoma; altered phosphorylation and expression patterns linked to tumor behavior)Pulmonary disease (variants and expression correlate with chronic obstructive pulmonary disease, airway remodeling)Developmental anomalies (implicated in developmental processes through ECM/cell adhesion modulation)Other (tissue homeostasis, renal, and cardiac function disturbances)
04

Biomarkers

Variant alleles and expression patterns may be biomarker candidates for chronic obstructive pulmonary disease risk and progression[3].Altered tyrosine phosphorylation in some cancers (e.g., lung adenocarcinoma)[3].

Beyond the preview

Go deeper on Tensin-1 (TNS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tensin-1 (TNS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call